A Study of CM350 in Patients With Advanced Solid Tumors

Clinical trial NCT05263960 · RECRUITING

Trial details

NCT number: NCT05263960
Sponsor: Keymed Biosciences Co.Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-04-21
Primary completion: 2027-04-01
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.